@ -25,7 +25,8 @@ Hyrimoz, Idacio, Simlandi, Yuflyma, and Yusimry),
the biosimilars are required to prove they have similar efficacy and safety to the
reference drug.
When registering these clinical trials
When registering a clinical trial,
the investigators are required to
% discuss how these are registered and what data is published.
% Include image and discuss stages
% Discuss challenges faced